Articles
Optimising Heart Failure Therapies in the Acute Setting
Citation:
Cardiac Failure Review 2018;4(1):38–42.
Fulminant Myocarditis: A Review of the Current Literature
Citation:
US Cardiology Review 2018;12(1):13–6.
Secondary Prevention in Patients with Non Valvular Atrial Fibrillation and Previous Stroke. Is It Possible to Have an Appropriate INR Control?
Citation:
European Cardiology Review 2017;12(2):103.
Curcumin Analogue GO-Y030 Significantly Improves Pressure Overload-induced Heart Failure in Vivo
Citation:
European Cardiology Review 2017;12(2):106.
Analysis of Factors Associated with Smoking Relapse
Citation:
European Cardiology Review 2017;12(2):111.
A Novel Target Molecule of Nobiletin Derived from Citrus Peels has a Therapeutic Potency Against the Development of Heart Failure
Citation:
European Cardiology Review 2017;12(2):105.
A Transcriptional Co-activator, p300 is Involved in the Epigenetic Gene Activation on Hypertrophic Response Gene Promoters in Heart Failure
Citation:
European Cardiology Review 2017;12(2):110.
Consensus is Possible: Initiation and Exchange of Oral Anticoagulants in Non-valvular Atrial Fibrillation, According to a Territorial Protocol in a Period of Time
Citation:
European Cardiology Review 2017;12(2):104.
The Inhibitory Effects of Curcumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine-Induced Responses in Cardiomyocytes
Citation:
European Cardiology Review 2017;12(2):107.
Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker
Citation:
European Cardiology Review 2017;12(2):96.
